主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CLDX
#3995
Celldex Therapeutics, Inc
30.090
0
+0.40%
版块:
基础:
利润货币:
日范围
年范围
日变化
+0.40%
每月变动
+14.80%
6个月变化
+10.46%
年变化
+10.46%
前一天收盘价
29.970
0
Open
30.000
0
Bid
Ask
Low
30.000
0
High
30.090
0
交易量
102
市场
股票
医疗保健
CLDX
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
66.34 M
66.38 M
66.39 M
66.41 M
66.45 M
66.57 M
—
Valuation ratios
Enterprise value
2.22 B
1.65 B
1.19 B
1.33 B
1.68 B
1.78 B
5.98 B
Price to earnings ratio
-13.17
-10.31
-6.72
-6.76
-7.65
-6.96
-28.1
Price to sales ratio
0.2
0.23
0.16
0.23
0.65
1.17
2.21
Price to cash flow ratio
0.01
0.01
0.01
0.01
0.01
0.01
0.03
Price to book ratio
0
0
0
0
0
0
0
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.06
-0.02
0.08
0.08
0.1
0.14
0.41
Return on equity %
0.07
-0.02
0.09
0.09
0.11
0.15
0.44
Return on invested capital %
—
-113.71
—
—
—
-176.27
—
Gross margin %
100
100
100
100
100
100
400
Operating margin %
1 633.53
4 768.26
9 027.19
8 747.53
-7.36 M
72.03 K
-7.27 M
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
1 633.53
-1 145.36
9 027.19
7 753.97
-6.7 M
67.24 K
-6.62 M
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
24.27
18.91
21.67
19.67
13.01
10.49
64.83
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
0
0
-0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
834.69
504.67
819.49
662.73
731.71
962.71
3 176.63
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
11.4 K
11.26 K
10.14 K
9 494.17
8 780.83
7 807.25
36.22 K
Net current asset value per share
11.75 K
11.6 K
10.45 K
9 766.3
9 098.75
8 049.5
37.37 K
Tangible book value per share
11.44 K
11.18 K
10.18 K
9 462.22
8 599.41
7 527.25
35.77 K
Working capital per share
11.26 K
10.99 K
9 968.5
9 269.81
8 399.19
7 281.82
34.92 K
Book value per share
11.85 K
11.6 K
10.59 K
9 871.76
9 008.78
7 936.6
37.41 K
新闻
Celldex公布慢性荨麻疹治疗的二期临床数据
Celldex presents phase 2 data for chronic urticaria treatment
Celldex Therapeutics Stock Earns 88 RS Rating
Celldex TherapeuticsQ4每股收益及营收逊于预期
Celldex Therapeutics earnings missed by $0.21, revenue fell short of estimates
Celldex Therapeutics股价触及52周高点30.66美元
Celldex Therapeutics stock hits 52-week high at 30.66 USD
Stifel重申Celldex Therapeutics评级,关注试验进展
Stifel reiterates Celldex Therapeutics stock rating on trial progress
Celldex提前六个月完成慢性自发性荨麻疹治疗的三期临床试验入组
Celldex completes Phase 3 enrollment for CSU treatment ahead of schedule
Cantor Fitzgerald重申Celldex股票评级为"增持"